CME: Preventing group B streptococcal infections with targeted therapy

Article

Since the CDC recommendations have been put into practice, we've seen a dramatic decline in early-onset neonatal GBS infections. But an expert in the field discusses several unresolved issues and emphasizes the need for continued vigilance to keep the disease under control.

Related Videos
The importance of nipocalimab’s FTD against FNAIT | Image Credit:  linkedin.com
The importance of maternal vaccination | Image Credit: nfid.org.
Sean Esplin, MD
Jonathan Miller, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.